Sherbrooke Park Advisers LLC acquired a new stake in Blend Labs, Inc. (NYSE:BLND – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 64,417 shares of the company’s stock, valued at approximately $271,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of BLND. Principal Financial Group Inc. lifted its stake in shares of Blend Labs by 697.6% during the 3rd quarter. Principal Financial Group Inc. now owns 2,733,004 shares of the company’s stock worth $10,249,000 after buying an additional 2,390,337 shares during the last quarter. Swiss National Bank lifted its stake in shares of Blend Labs by 3.5% during the 4th quarter. Swiss National Bank now owns 392,500 shares of the company’s stock worth $1,652,000 after buying an additional 13,300 shares during the last quarter. Caprock Group LLC lifted its stake in shares of Blend Labs by 142.5% during the 4th quarter. Caprock Group LLC now owns 75,032 shares of the company’s stock worth $316,000 after buying an additional 44,096 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Blend Labs by 23.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 94,242 shares of the company’s stock worth $397,000 after buying an additional 17,914 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Blend Labs by 2.4% during the 4th quarter. Vanguard Group Inc. now owns 16,811,510 shares of the company’s stock worth $70,776,000 after buying an additional 388,583 shares during the last quarter. Institutional investors own 52.56% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have weighed in on the stock. UBS Group dropped their price objective on shares of Blend Labs from $4.00 to $3.50 and set a “neutral” rating for the company in a research note on Friday, February 28th. Canaccord Genuity Group reiterated a “buy” rating and issued a $5.25 price objective on shares of Blend Labs in a research note on Monday, May 12th. Wells Fargo & Company dropped their price objective on shares of Blend Labs from $6.00 to $5.00 and set an “overweight” rating for the company in a research note on Tuesday, April 22nd. Keefe, Bruyette & Woods boosted their target price on shares of Blend Labs from $3.50 to $4.00 and gave the company a “market perform” rating in a research report on Monday. Finally, The Goldman Sachs Group dropped their target price on shares of Blend Labs from $5.60 to $4.80 and set a “buy” rating for the company in a research report on Monday, May 12th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $4.90.
Blend Labs Trading Down 0.5%
Shares of Blend Labs stock opened at $3.64 on Tuesday. The firm has a market capitalization of $945.17 million, a PE ratio of -10.71 and a beta of 1.29. The firm’s 50 day moving average is $3.37 and its 200 day moving average is $3.88. Blend Labs, Inc. has a 1 year low of $2.08 and a 1 year high of $5.53.
Blend Labs Profile
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Featured Articles
- Five stocks we like better than Blend Labs
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Quiet Period Expirations Explained
- What Ray Dalio’s Latest Moves Tell Investors
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.